New non-alcohol germ protection spray now available in Greater Cleveland

NewsGuard 100/100 Score

MyClyns, the new non-alcohol germ protection spray, is now available to consumers over the counter throughout Greater Cleveland, one of two cities in the nation chosen as initial test market cities prior to a nationwide product launch. The MyClyns spray has been used and trusted by first responders, healthcare professionals, military and emergency workers for years and is now available on store shelves for the very first time.

MyClyns is the only germ protection spray that is safe to spray into the eyes, nose, mouth and minor cuts and abrasions -- places where germs commonly enter the body. Developed by Kentucky based Union Springs Pharmaceuticals, the solution found in MyClyns shows a 99.99 percent reduction of more than 60 pathogens in independent laboratory testing. The product has seen a spike in demand with the onset of the cold and flu season.

"MyClyns found significant success with public safety officials, as they are frequently exposed to any number of pathogens in the field," Union Springs Pharmaceuticals president Joel Ivers said. "That success led us logically to offer the same product to consumers, and the response has been overwhelming. It is available in a convenient consumer package, giving parents, office managers and travelers another way to help protect themselves and their families when exposed to sick people or public locations where there are potentially harmful germs."

Source:

MyClyns

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New study to test novel psychedelic compound as potential treatment for alcohol use disorder